Cigarette smoke exposure impairs reverse cholesterol transport which can be minimized by treatment of hydrogen-saturated saline

Lipids in Health and Disease

Volumn 14, Issue 1, 2015, Pages

  Zong, Chuanlong ^a   Song, Guohua ^a   Yao, Shutong ^a   Guo, Shoudong ^a   Yu, Yang ^a   Yang, Nana ^a   Guo, Zheng ^a   Qin, Shucun ^a  

^a TAISHAN MEDICAL UNIVERSITY   (China)

Author keywords

Cigarette smoke exposure; High density lipoprotein; Human CETP transgenic mice; Hydrogen; Reverse cholesterol transport

Indexed keywords

ANTIOXIDANT; CHOLESTEROL ESTER TRANSFER PROTEIN; CIGARETTE SMOKE; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROGEN SATURATED SALINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRITIUM CHOLESTEROL H 3; UNCLASSIFIED DRUG; CHOLESTEROL; HYDROGEN; LIPID; SODIUM CHLORIDE; SOLUTION AND SOLUBILITY;

ABCA1 GENE; ABCG1 GENE; ABCG5 GENE; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIOXIDANT ACTIVITY; ARTICLE; BILE LEVEL; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; CYP7A1 GENE; EXPOSURE; FECES LEVEL; GENE; GENE EXPRESSION; IN VIVO STUDY; LDLR GENE; LIVER LEVEL; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; REVERSE CHOLESTEROL TRANSPORT; SRBI GENE; ADVERSE EFFECTS; ANIMAL; ATHEROSCLEROSIS; BLOOD; C57BL MOUSE; METABOLISM; OXIDATIVE STRESS; PRECLINICAL STUDY; RAW 264.7 CELL LINE; SECRETION (PROCESS); SMOKING; SOLUTION AND SOLUBILITY;

ANIMALS; ATHEROSCLEROSIS; BODY WEIGHT; CHOLESTEROL; DRUG EVALUATION, PRECLINICAL; HYDROGEN; LIPIDS; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED C57BL; OXIDATIVE STRESS; RAW 264.7 CELLS; SMOKING; SODIUM CHLORIDE; SOLUTIONS;

EID: 84949662371     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/s12944-015-0160-9     Document Type: Article

References (44)

1. Glomset JA. The plasma lecithins:cholesterol acyltransferase reaction. J Lipid Res. 1968;9:155-67.
2. Lewis GF, Rader DJ. New insights into the regulation of HDL metabolism and reverse cholesterol transport. Circ Res. 2005;96:1221-32.
3. Cuchel M, Rader DJ. Macrophage reverse cholesterol transport: key to the regression of atherosclerosis? Circulation. 2006;113:2548-55.
4. Agellon LB, Walsh A, Hayek T, Moulin P, Jiang XC, Shelanski SA, et al. Reduced high density lipoprotein cholesterol in human cholesteryl ester transfer protein transgenic mice. J Biol Chem. 1991;266:10796-801.
5. Hesler CB, Tall AR, Swenson TL, Weech PK, Marcel YL, Milne RW. Monoclonal antibodies to the Mr 74,000 cholesteryl ester transfer protein neutralize all of the cholesteryl ester and triglyceride transfer activities in human plasma. J Biol Chem. 1988;263:5020-3.
6. Dinchuk J, Hart J, Gonzalez G, Karmann G, Schmidt D, Wirak DO. Remodelling of lipoproteins in transgenic mice expressing human cholesteryl ester transfer protein. Biochim Biophys Acta. 1995;1255:301-10.
7. Craig WY, Palomaki GE, Haddow JE. Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. BMJ. 1989;298:784-8.
8. Alonso M, Godayol A, Antico' E, Sanchez JM. Assessment of environmental tobacco smoke contamination in public premises: significance of 2,5-dimethylfuran as an effective marker. Environ Sci Technol. 2010;44:8289-94.
9. Gokulakrisnan A, Jayachandran Dare B, Thirunavukkarasu C. Attenuation of the cardiac inflammatory changes and lipid anomalies by (-)-epigallocatechin-gallate in cigarette smoke-exposed rats. Mol Cell Biochem. 2011;354(1-2):1-10.
10. Freeman TL, Haver A, Duryee MJ, Tuma DJ, Klassen LW, Hamel FG, et al. Aldehydes in cigarette smoke react with the lipid peroxidation product malonaldehyde to form fluorescent proteinadducts on lysines. Chem Res Toxicol. 2005;18(5):817-24.
11. Nagano Y, Arai H, Kita T. High density lipoprotein loses its effect to stimulate efflux of cholesterol from foam cells after oxidative modification. Proc Natl Acad Sci. 1997;88:6457-61.
12. Song G, Tian H, Qin S, Sun X, Yao S, Zong C, et al. Hydrogen decreases athero-susceptibility in apolipoprotein B-containing lipoproteins and aorta of apolipoprotein E knockout mice. Atherosclerosis. 2012;221(1):55-65.
13. Song G, Li M, Sang H, Zhang L, Li X, Yao S, et al. Hydrogen-rich water decreases serum LDL-cholesterol levels and improves HDL function in patients with potential metabolic syndrome. J Lipid Res. 2013;54(7):1884-93.
14. Zong C, Song G, Yao S, Li L, Yu Y, Feng L, et al. Administration of hydrogen-saturated saline decreases plasma low-density lipoprotein cholesterol levels and improves high-density lipoprotein function in high-fat diet-fed hamsters. Metabolism. 2012;61(6):794-800.
15. Miyazaki A, Sakai M, Suginohara Y, Hakamata H, Sakamoto Y, Morikawa W, et al. Acetylated low density lipoprotein reduces its ligand activity for the scavenger receptor after interaction with reconstituted high density lipoprotein. J Biol Chem. 1994;269(7):5264-9.
16. Escolar JD, Martinez MN, Rodriguez FJ, Gonzalo C, Escolar MA, Roche PA. Emphysema as a result of involuntary exposure to tobacco smoke: morphometrical study of the rat. Exp Lung Res. 1995;21:255-73.
17. Yu Y, Si Y, Song G, Luo T, Wang J, Qin S. Ethanolic Extract of Propolis Promotes Reverse Cholesterol Transport and the Expression of ATP-Binding Cassette Transporter A1 and G1 in Mice. Lipids. 2011;46(9):805-11.
18. Smith JD, Miyata M, Ginsberg M, Grigaux C, Shmookler E, Plump AS. Cyclic AMP induces apolipoprotein E binding activity and promotes cholesterol efflux from a macrophage cell line to apolipoprotein acceptors. J Biol Chem. 1996;271:30647-55.
19. Rikitake Y, Hirata K, Kawashima S, Akita H, Yokoyama M. Inhibitory effect of inducible type nitric oxide synthase on oxidative modification of low density lipoprotein by vascular smooth muscle cells. Atherosclerosis. 1998;136:51-7.
20. Smith CJ, Fischer TH. Particulate and vapor phase constituents of cigarette mainstream smoke and risk of myocardial infarction. Atherosclerosis. 2001;158:257-67.
21. Botti TP, Amin H, Hiltscher L, Wissler RW. A comparison of the quantitation of macrophage foam cell populations and the extent of apolipoprotein E deposition in developing atherosclerotic lesions in young people: high and low serum thiocyanate groups as an indication of smoking. PDAY Research Group. Pathobiological Determinants of Atherosclerosis in Youth. Atherosclerosis. 1996;124:191-202.
22. Bazin M, Turcotte H, Lagace R, Boutet M. Cardiovascular effects of cigarette smoke in the rat. Aortic endothelial and myocardial capillary permeability in the rat. Rev Can Biol. 1981;40:263-76.
23. Ohsawa I, Ishikawa M, Takahashi K, Watanabe M, Nishimaki K, Yamagata K, et al. Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nat Med. 2007;13:688-94.
24. Kajiyama S, Hasegawa G, Asano M, Hosoda H, Fukui M, Nakamura N, et al. Supplementation of hydrogen-rich water improves lipid and glucose metabolism in patients with type 2 diabetes or impaired glucose tolerance. Nutr Res. 2008;28:137-43.
25. Suzuki Y, Sano M, Hayashida K, Ohsawa I, Ohta S, Fukuda K. Are the effects of alpha-glucosidase inhibitors on cardiovascular events related to elevated levels of hydrogen gas in the gastrointestinal tract. FEBS Lett. 2009;583:2157-9.
26. Ohsawa I, Nishimaki K, Yamagata K, Ishikawa M, Ohta S. Consumption of hydrogen water prevents atherosclerosis in apolipoprotein E knockout mice. Biochem Biophys Res Commun. 2008;377:1195-8.
27. Hodhod MA, Hamdy AM, Ahmed MB, Youssef SR, Aly SM. Effect of passive smoking on blood lymphocyte apoptosis in children. Eur J Clin Invest. 2011;41(4):387-92.
28. Damasceno DC, Sinzato YK, Bueno A, Dallaqua B, Lima PH, Calderon IM, et al. Metabolic profile and genotoxicity in obese rats exposed to cigarette smoke. Obesity (Silver Spring). 2013;21(8):1596-601.
29. Esteve E, Ricart W, Fernandez-Real JM. Dyslipidemia and inflammation: an evolutionary conserved mechanism. Clin Nutr. 2005;24:16-31.
30. Van Lenten BJ, Navab M, Shih D, Fogelman AM, Lusis AJ. The role of high-density lipoproteins in oxidation and inflammation. Trends Cardiovasc Med. 2001;11(3-4):155-61.
31. McCall MR, van den Berg JJM, Kuypers FA, Tribble DL, Krauss RM, Knoff LJ, et al. Modification of LCAT activity and HDL structure: new links between cigarette smoke and CHD risk. Arterioscler Thromb. 1994;14:248-53.
32. Bielicki JK, McCall MR, van den Berg JJM, Kuypers FA, Forte TM. Copper and gas-phase cigarette smoke inhibit plasma 1ecithin:cholesterol acyltransferase activity by different mechanisms. J Lipid Res. 1995;36:322-31.
33. Marangon K, Herbeth B, Lecomte E, Paul-Dauphin A, Grolier P, Chancerelle Y, et al. Diet, antioxidant status, and smoking habits in French men. Am J Clin Nutr. 1998;67:231-9.
34. Karvonen J, Kauma H, Kervinen K, Ukkola O, Rantala M, Päivänsalo M, et al. Apolipoprotein E polymorphism affects carotid artery atherosclerosis in smoking hypertensive men. J Hypertens. 2002;20:2371-8.
35. Wang N, Silver DL, Costet P, Tall AR. Specific binding of ApoA-I, enhanced cholesterol efflux, and altered plasma membrane morphology in cells expressing ABC1. J Biol Chem. 2000;275:33053-8.
36. Oram JF, Lawn RM, Garvin MR, Wade DP. ABCA1 is the cAMP-inducible apolipoprotein receptor that mediates cholesterol secretion from macrophages. J Biol Chem. 2000;275:34508-11.
37. Bortnick AE, Rothblat GH, Stoudt G, Hoppe KL, Royer LJ, McNeish J, et al. The correlation of ATP-binding cassette 1 mRNA levels with cholesterol efflux from various cell lines. J Biol Chem. 2000;275:28634-40.
38. Yancey PG, de la Llera-Moya M, Swarnakar S, Monzo P, Klein SM, Connelly MA, et al. High density lipoprotein phospholipid composition is a major determinant of the bi-directional flux and net movement of cellular free cholesterol mediated by scavenger receptor BI. J Biol Chem. 2000;275:36596-604.
39. Wang N, Lan D, Chen W, Matsuura F, Tall AR. ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins. Proc Natl Acad Sci. 2004;101:9774-9.
40. Kennedy MA, Barrera GC, Nakamura K, Baldan A, Tarr P, Fishbein MC, et al. ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation. Cell Metab. 2005;1:121-31.
41. Pietro S, Matteo C, Maria M. Nutraceuticals and dyslipidaemia: Beyond the common therapeutics. Journal of Functional Foods. 2014;6:11-32.
42. Zuchi C, Ambrosio G, Luscher TF, Landmesser U. Nutraceuticals in cardiovascular prevention: Lessons from studies on endothelial function. Cardiovasc Ther. 2010;28:187-201. 202-215.
43. Chakrabarti S, Freedman JE. Review: Nutriceuticals as antithrombotic agents. Cardiovasc Ther. 2010;28:227-35.
44. Rahimi-Ardabili B, Argani H, Ghorbanihaghjo A, Rashtchizadeh N, Naghavi-Behzad M, Ghorashi S, et al. Paraoxonase enzyme activity is enhanced by zinc supplementation in hemodialysis patients. Ren Fail. 2012;34:1123-8.